Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-25 @ 1:37 PM
NCT ID: NCT03405792
Term: Intra-operative injury, muscle
Organ System: Surgical and medical procedures
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE version 4.0
Notes: None
Study: NCT03405792
Study Brief: Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (OptuneĀ®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 1 28 View
EG001 None 0 456 View